The patient had an unreported heterozygous de novo sequence variant in ATP1A3, and have been found to be of a phenotype characterized by early-onset attacks of movement disorders, which proved to be epileptic, and severe developmental delay. This evidence concerns the gene ATP1A3 and movement disorder.